Rethinking Menopause Hormone Therapy

• by Kerri Miller

• April 23, 2026

Patient-Reported Symptoms in Climacteric Syndrome: Insights from a Network Analysis at a Single Center

• by Su-Ji Choi, Bongsu Kang, Chang-Eop Kim, Dong-Il Kim

• April 5, 2026

ACP Suggests First-Line Obesity Drugs

Semaglutide and tirzepatide had the greatest net benefit among evaluated treatments, the committee concluded.

• by Kathryn Wighton

• June 16, 2026

• 5 min

Menopause Apps Offer Empowerment, but Pose Risks

• by Wendy Glauser

• July 13, 2026